AVITA Medical Inc. (RCEL) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AVITA Medical Inc.

    NASDAQ: RCEL · Real-Time Price · USD
    5.54
    0.07 (1.28%)
    At close: Oct 03, 2025, 3:59 PM
    5.47
    -1.26%
    After-hours: Oct 03, 2025, 06:52 PM EDT

    AVITA Medical Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -61.84M -35.38M -26.66M -25.14M
    Depreciation & Amortization
    		 1.13M 632K 568K 969K
    Stock-Based Compensation
    		 13.5M 8.38M 7M 6.33M
    Other Working Capital
    		 1.31M -386K -122K -391K
    Other Non-Cash Items
    		 2.96M -5.07M 1.21M 1.53M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -4.68M -6.57M -1.2M -1.73M
    Operating Cash Flow
    		 -48.94M -38.01M -19.09M -18.04M
    Capital Expenditures
    		 -9.33M -1.45M -525K -487K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -24.5M -78.76M -74.36M n/a
    Sales Maturities Of Investments
    		 71.2M 81.81M 55.55M n/a
    Other Investing Acitivies
    		 -162K -66K -73K -49.72M
    Investing Cash Flow
    		 37.36M 1.61M -19.33M -50.21M
    Debt Repayment
    		 n/a 38.76M n/a -11K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 3.51M 1.61M 900K 64.08M
    Financial Cash Flow
    		 3.51M 40.37M 900K 64.06M
    Net Cash Flow
    		 -8.07M 3.95M -37.55M 37.11M
    Free Cash Flow
    		 -58.27M -39.46M -19.61M -18.52M

    Add to Watchlist